The C allele of -634G/C polymorphism in the VEGFA gene is associated with increased VEGFA gene expression in human retinal tissue

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 10, 2012, Pages 6411-6415

  Vailati, Fabiana B ^a   Crispim, Daisy ^a   Sortica, Denise A ^a   Souza, Bianca M ^a   Brondani, Letícia A ^a   Canani, Luís H ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; ENUCLEATION; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPING TECHNIQUE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A GENE; CADAVER; DONOR; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; PHYSIOLOGY; RETINA; RETINA BLOOD VESSEL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS;

ADOLESCENT; ADULT; AGED; ALLELES; CADAVER; CROSS-SECTIONAL STUDIES; DIABETIC RETINOPATHY; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RETINA; RETINAL VESSELS; RISK FACTORS; TISSUE DONORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84871882197     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-9727     Document Type: Article

References (32)

1. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267: 10931-10934.
2. Zetter BR. Angiogenesis. State of the art. Chest. 1988;93:159S-166S.
3. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes Memorial Award lecture. Cancer Res. 1986;46:467-473.
4. Polverini PJ. The pathophysiology of angiogenesis. Crit Rev Oral Biol Med. 1995;6:230-247.
5. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995;146:1029-1039.
6. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25:581-611.
7. Crawford TN, Alfaro DV III, Kerrison JB, Jablon EP. Diabetic retinopathy and angiogenesis. Curr Diabetes Rev. 2009;5:8-13.
8. Virgintino D, Ozerdem U, Girolamo F, Roncali L, Stallcup WB, Perris R. Reversal of cellular roles in angiogenesis: implications for anti-angiogenic therapy. J Vasc Res. 2008;45:129-131.
9. Capp C, Zennig N, Wajner SM, Maia AL. Papel do fator de crescimento endotelial vascular nos carcinomas de tiréoide. Revista HCPA. 2009;29:51-59.
10. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18:4-25.
11. Vincenti V, Cassano C, Rocchi M, Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation. 1996;93:1493-1495.
12. Paques M, Massin P, Gaudric A. Growth factors and diabetic retinopathy. Diabetes Metab. 1997;23:125-130.
13. Nagy JA, Benjamin L, Zeng H, Dvorak AM, Dvorak HF. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis. 2008;11:109-119.
14. Tischer E, Mitchell R, Hartman T, et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem. 1991; 266:11947-11954.
15. Gerber HP, Hillan KJ, Ryan AM, et al. VEGF is required for growth and survival in neonatal mice. Development. 1999; 126:1149-1159.
16. Kim I, Ryan AM, Rohan R, et al. Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. Invest Ophthalmol Vis Sci. 1999;40:2115-2121.
17. Saint-Geniez M, Maharaj JS, Walshe TE, et al. Endogenous VEGF is required for visual function: evidence for a survival role on M̈uller cells and photoreceptors. PLoS One. 2008;3: pe3554.
18. Errera FI, Canani LH, Silva ME, et al. Functional vascular endothelial growth factor _634G>C SNP is associated with proliferative diabetic retinopathy: a case-control study in a Brazilian population of European ancestry. Diabetes Care. 2007;30:275-279.
19. Awata T, Inoue K, Kurihara S, et al. A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes. 2002; 51:1635-1639.
20. Awata T, Kurihara S, Takata N, et al. Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes. Biochem Biophys Res Commun. 2005;333: 679-685.
21. Szaflik JP, Wysocki T, Kowalski M, et al. An association between vascular endothelial growth factor gene promoter polymorphisms and diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2008;246:39-43.
22. Suganthalakshmi B, Anand R, Kim R, et al. Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol Vis. 2006;12:336-341.
23. Kangas-Kontio T, Vavuli S, Kakko SJ, et al. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy. Br J Ophthalmol. 2009;93:1401-1406.
24. Nakamura S, Iwasaki N, Funatsu H, Kitano S, Iwamoto Y. Impact of variants in the VEGF gene on progression of proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2009;247:21-26.
25. Petrovic MG, Korosec P, Kosnik M, et al. Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy. Mol Vis. 2008; 14:1382-1387.
26. Bustin SA, Benes V, Garson JA, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55:611-622.
27. Higuchi R, Fockler C, Dollinger G, Watson R. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (N Y). 1993;11:1026-1030.
28. Relative Quantitation of Gene Expression Experimental Design and Analysis: Relative Standard Curve Method and Comparative CT Method (Delta Delta-CT). Guide to Performing Relative Quantitation of Gene Expression Using Real-Time Quantitative PCR. Foster City, CA: Applied Biosystems; 2004.
29. Shastry BS. SNPs and haplotypes: genetic markers for disease and drug response. Int J Mol Med. 2003;11:379-382.
30. Smith CP, Steinle JJ. Changes in growth factor expression in normal aging of the rat retina. Exp Eye Res. 2007;85:817-824.
31. Ferrara N, Keyt B. Vascular endothelial growth factor: basic biology and clinical implications. EXS. 1997;79:209-232.
32. Hefler LA, Mustea A, K̈onsgen D, et al. Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer. Clin Cancer Res. 2007;13:898-901.